Literature DB >> 18059655

Descriptive summary of an outbreak of porcine post-weaning multisystemic wasting syndrome (PMWS ) in New Zealand.

E J Neumann1, S S A Dobbinson, E B M Welch, R S Morris.   

Abstract

CASE HISTORY: Investigations were conducted to determine the cause of an acute, multi-farm outbreak of porcine respiratory disease that included diarrhoea and subsequent loss of body condition in affected pigs. A definition for post-weaning multisystemic wasting syndrome (PMWS) including both clinical and pathological features, previously developed for the pig industry in New Zealand, was applied to the current outbreak. In addition to self-reporting by owners of affected farms, local veterinarians, disease and epidemiology consultants, and animal health officials from the Ministry of Agriculture and Forestry (MAF) were involved in conducting farm visits and submission of diagnostic specimens. CLINICAL FINDINGS AND DIAGNOSIS: Pathogens known to be endemic in the pig industry in New Zealand as well as likely exotic diseases were excluded as causative agents of the outbreak. Clinical signs including dyspnoea, diarrhoea, and rapid loss of body condition were consistent with the New Zealand case definition for PMWS. Interstitial pneumonia, pulmonary oedema, generalised lymph-node enlargement, and presence of porcine circovirus type 2 (PCV2) inclusion bodies were consistently identified in affected pigs. Classical swine fever virus (CSFv), Porcine reproductive and respiratory syndrome virus (PRRSv), and Influenza virus were ruled out, using molecular and traditional virological techniques. Spread of the disease between farms was hypothesised to be facilitated by locally migrating flocks of black-backed seagulls. The original source of the disease incursion was not identified. DIAGNOSIS: Based on the consistent presence of circovirus-associated lesions in lymphoid tissues in combination with generalised enlargement of lymph nodes, histiocytic interstitial pneumonia, clinical wasting, and poor response to antibiotic therapy, a diagnosis of PMWS was made. CLINICAL RELEVANCE: PMWS should be considered in the differential diagnoses of sudden onset of respiratory dyspnoea, diarrhoea, and rapid loss of body condition in young pigs in New Zealand pig herds.

Entities:  

Mesh:

Year:  2007        PMID: 18059655     DOI: 10.1080/00480169.2007.36792

Source DB:  PubMed          Journal:  N Z Vet J        ISSN: 0048-0169            Impact factor:   1.628


  5 in total

1.  Characterization of a complete genome of a circular single-stranded DNA virus from porcine stools in Korea.

Authors:  A Reum Kim; Hee Chun Chung; Hye Kwon Kim; Eun Ok Kim; Van Giap Nguyen; Min Gyung Choi; Hye Jung Yang; Jung Ah Kim; Bong Kyun Park
Journal:  Virus Genes       Date:  2013-10-30       Impact factor: 2.332

2.  Genomic analysis of porcine circovirus type-2 isolates in Alberta pigs demonstrating clinical porcine circovirus associated disease (PCVAD).

Authors:  Leila McIntyre; Mark Chaiyakul; Edward G Clark; Frank Marshall; Markus Czub
Journal:  Can J Vet Res       Date:  2010-04       Impact factor: 1.310

3.  Novel circular DNA viruses in stool samples of wild-living chimpanzees.

Authors:  Olga Blinkova; Joseph Victoria; Yingying Li; Brandon F Keele; Crickette Sanz; Jean-Bosco N Ndjango; Martine Peeters; Dominic Travis; Elizabeth V Lonsdorf; Michael L Wilson; Anne E Pusey; Beatrice H Hahn; Eric L Delwart
Journal:  J Gen Virol       Date:  2009-09-16       Impact factor: 3.891

4.  Spread of porcine circovirus associated disease (PCVAD) in Ontario (Canada) swine herds: Part I. Exploratory spatial analysis.

Authors:  Zvonimir Poljak; Catherine E Dewey; Thomas Rosendal; Robert M Friendship; Beth Young; Olaf Berke
Journal:  BMC Vet Res       Date:  2010-12-30       Impact factor: 2.741

5.  Spread of porcine circovirus associated disease (PCVAD) in Ontario (Canada) swine herds: Part II. Matched case-control study.

Authors:  Zvonimir Poljak; Catherine E Dewey; Thomas Rosendal; Robert M Friendship; Beth Young; Olaf Berke
Journal:  BMC Vet Res       Date:  2010-12-29       Impact factor: 2.741

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.